glutathione diethyl ester has been researched along with lysophosphatidylcholines in 1 studies
| Studies (glutathione diethyl ester) | Trials (glutathione diethyl ester) | Recent Studies (post-2010) (glutathione diethyl ester) | Studies (lysophosphatidylcholines) | Trials (lysophosphatidylcholines) | Recent Studies (post-2010) (lysophosphatidylcholines) |
|---|---|---|---|---|---|
| 8 | 0 | 0 | 5,058 | 39 | 976 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doi, H; Kugiyama, K; Matsumura, T; Miles, LA; Oka, H; Shibata, H; Sugiyama, S; Yasue, H | 1 |
1 other study(ies) available for glutathione diethyl ester and lysophosphatidylcholines
| Article | Year |
|---|---|
Lysophosphatidylcholine induces urokinase-type plasminogen activator and its receptor in human macrophages partly through redox-sensitive pathway.
Topics: Acetylcysteine; Arteriosclerosis; Glutathione; Humans; In Vitro Techniques; Lysophosphatidylcholines; Macrophages; Oxidation-Reduction; Oxidative Stress; Peptide Fragments; Reactive Oxygen Species; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; RNA, Messenger; Superoxides; Up-Regulation; Urokinase-Type Plasminogen Activator | 2000 |